title: Role of nitric oxide in gonadotropin-releasing hormone-dependent prostaglandin F2 alpha synthesis by frog (Rana esculenta) interrenal gland during post-reproduction.
abstract: The aim of this study was to clarify the possible involvement of nitric oxide (NO) on prostaglandin (PG) E2-9-ketoreductase activity in the gonadotropin-releasing hormone (GnRH)-dependent PGF2 alpha synthesis by the interrenal gland of the female water frog, Rana esculenta, during the post-reproduction. Interrenal glands were incubated in vitro with GnRH, NO donor (sodium nitroprusside, SNP), and inhibitors of phospholipase C (compound 48/80), inositol triphosphate (decavanadate), calmodulin (calmidazolium), NO synthase (L-NAME), and PGE2-9-ketoreductase (palmitic acid). Production of PGE2 and PGF2 alpha and NO synthase and PGE2-9-ketoreductase activities were determined. GnRH and SNP increased PGF2 alpha production and PGE2-9-ketoreductase activity, and decreased production of PGE2 and GnRH increased NO synthase activity. GnRH effects were blocked by all inhibitors, except for palmitic acid, which did not affect NO synthase activity, which is increased by GnRH. This study indicates that NO may be involved in regulation of the R. esculenta post-reproduction through stimulation of PGE2-9-ketoreductase activity in GnRH-dependent PGF2 alpha synthesis by the frog interrenal gland.
authors.affiliation: Department of Molecular, Cellular, and Animal Biology, University of Camerino, Italy. goz@camserv.unicam.it
authors.forename: A
authors.initials: A
authors.lastname: Gobbetti
authors.forename: L
authors.initials: L
authors.lastname: Bellini-Cardellini
authors.forename: M
authors.initials: M
authors.lastname: Zerani
mesh_terms: D000818:Animals; D015237:Dinoprost / Q000096:biosynthesis*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology*; D006911:Hydroxyprostaglandin Dehydrogenases / Q000187:drug effects; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D007401:Interrenal Gland / Q000187:drug effects*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000494:pharmacology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D009599:Nitroprusside / Q000494:pharmacology; D019308:Palmitic Acid / Q000494:pharmacology; D011893:Rana esculenta / Q000378:metabolism*; D012098:Reproduction; D015398:Signal Transduction; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors; D014638:Vanadates / Q000494:pharmacology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
chemical_list: D007093:Imidazoles; D009599:Nitroprusside; D019308:Palmitic Acid; D009569:Nitric Oxide; D007987:Gonadotropin-Releasing Hormone; D014638:Vanadates; D003189:p-Methoxy-N-methylphenethylamine; C031938:calmidazolium; D015237:Dinoprost; D006911:Hydroxyprostaglandin Dehydrogenases; C035858:prostaglandin-E2 9-reductase; D019001:Nitric Oxide Synthase; D010738:Type C Phospholipases; D019331:NG-Nitroarginine Methyl Ester